Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer.
Rosenberg
S A
SA
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1502, USA.
D000951:Antigens, Neoplasm / Q000032:analysis / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000494:pharmacology / Q000627:therapeutic use*; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D058965:MART-1 Antigen; D009363:Neoplasm Proteins / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*
D000951:Antigens, Neoplasm; D007376:Interleukin-2; D058965:MART-1 Antigen; C548667:MLANA protein, human; D009363:Neoplasm Proteins